Literature DB >> 4015938

Measurement of plasma catecholamine concentrations. An assessment of anxiety.

D Fell, D R Derbyshire, C J Maile, I M Larsson, R Ellis, K J Achola, G Smith.   

Abstract

This study was designed to assess the value of measurement of plasma catecholamine concentrations as an objective index of anxiety. A preliminary study was undertaken on 11 healthy volunteers (medically qualified), to determine if venous cannulation per se produced any change in plasma catecholamine concentrations. There were no changes in plasma catecholamine concentrations in the 2 h following insertion of an i.v. cannula, suggesting that venous cannulation did not induce a measurable stress response. A second study was performed on 48 surgical patients who were asked to rate their perceived anxiety on a linear analogue scale immediately before premedication and immediately before induction of anaesthesia. Venous blood was obtained at the same time as these ratings. There were no significant changes in perceived anxiety or plasma noradrenaline concentrations following premedication. However, compared with values before premedication, there was a mean percentage increase in plasma adrenaline concentration of 40% before induction of anaesthesia. A significant correlation was shown between mean percentage change in Linear Analogue Anxiety Score and mean percentage change in plasma adrenaline concentrations (r = 0.32).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4015938     DOI: 10.1093/bja/57.8.770

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  14 in total

1.  The relationship of preoperative distress to endocrine and subjective responses to surgery: support for Janis' theory.

Authors:  P Salmon; S Pearce; C C Smith; A Heys; A Manyande; N Peters; J Rashid
Journal:  J Behav Med       Date:  1988-12

Review 2.  Anaesthetic premedication: aims, assessment and methods.

Authors:  T H Madej; R T Paasuke
Journal:  Can J Anaesth       Date:  1987-05       Impact factor: 5.063

3.  Preoperative Needs-Based Education to Reduce Anxiety, Increase Satisfaction, and Decrease Time Spent in Day Surgery: A Randomized Controlled Trial.

Authors:  Apinut Wongkietkachorn; Nuttapone Wongkietkachorn; Peera Rhunsiri
Journal:  World J Surg       Date:  2018-03       Impact factor: 3.352

4.  Availability of preoperative anxiety scale as a predictive factor for hemodynamic changes during induction of anesthesia.

Authors:  Won-Sung Kim; Gyeong-Jo Byeon; Bong-Jae Song; Hyeon Jeong Lee
Journal:  Korean J Anesthesiol       Date:  2010-04-28

5.  Increased urinary tribulin output in generalised anxiety disorder.

Authors:  A Clow; V Glover; M Sandler; J Tiller
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

6.  Patient knowledge of operative care.

Authors:  O A Williams
Journal:  J R Soc Med       Date:  1993-06       Impact factor: 5.344

7.  Patient-reported pain, discomfort, and anxiety during magnetic resonance imaging-targeted prostate biopsy.

Authors:  Gregory T Chesnut; Piotr Zareba; Daniel D Sjoberg; Maha Mamoor; Sigrid Carlsson; Taehyoung Lee; Jonathan Fainberg; Emily Vertosick; Michael Manasia; Mary Schoen; Behfar Ehdaie
Journal:  Can Urol Assoc J       Date:  2019-11-29       Impact factor: 1.862

8.  Extended preoperative patient education using a multimedia DVD-impact on patients receiving a laparoscopic cholecystectomy: a randomised controlled trial.

Authors:  D Wilhelm; S Gillen; H Wirnhier; M Kranzfelder; A Schneider; A Schmidt; H Friess; H Feussner
Journal:  Langenbecks Arch Surg       Date:  2009-01-17       Impact factor: 3.445

Review 9.  Psychiatric Illness in Takotsubo (Stress) Cardiomyopathy: A Review.

Authors:  Arash Nayeri; Eric Rafla-Yuan; Srikanth Krishnan; Boback Ziaeian; Martin Cadeiras; John A McPherson; Quinn S Wells
Journal:  Psychosomatics       Date:  2018-02-02       Impact factor: 2.386

10.  The measurement of preoperative anxiety.

Authors:  J A Hicks; J G Jenkins
Journal:  J R Soc Med       Date:  1988-09       Impact factor: 18.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.